BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33710031)

  • 1. Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network.
    Wongtangman K; Grabitz SD; Hammer M; Wachtendorf LJ; Xu X; Schaefer MS; Fassbender P; Santer P; Kassis EB; Talmor D; Eikermann M;
    Crit Care Med; 2021 Jul; 49(7):1137-1148. PubMed ID: 33710031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Sedation, Coma, and In-Hospital Mortality in Mechanically Ventilated Patients With Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome: A Retrospective Cohort Study.
    Wongtangman K; Santer P; Wachtendorf LJ; Azimaraghi O; Baedorf Kassis E; Teja B; Murugappan KR; Siddiqui S; Eikermann M;
    Crit Care Med; 2021 Sep; 49(9):1524-1534. PubMed ID: 33861551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular Blocker Use in Critically Ill Children: Assessing Mortality Risk by Propensity Score-Weighted Analysis.
    Daverio M; Sperotto F; Stefani C; Mondardini MC; Tessari A; Biban P; Izzo F; Montani C; Lapi M; Picconi E; Racca F; Marinosci GZ; Savron F; Wolfler A; Amigoni A;
    Crit Care Med; 2022 Mar; 50(3):e294-e303. PubMed ID: 34582423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Neuromuscular Blockade in the Acute Respiratory Distress Syndrome.
    ; Moss M; Huang DT; Brower RG; Ferguson ND; Ginde AA; Gong MN; Grissom CK; Gundel S; Hayden D; Hite RD; Hou PC; Hough CL; Iwashyna TJ; Khan A; Liu KD; Talmor D; Thompson BT; Ulysse CA; Yealy DM; Angus DC
    N Engl J Med; 2019 May; 380(21):1997-2008. PubMed ID: 31112383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blockers in early acute respiratory distress syndrome.
    Papazian L; Forel JM; Gacouin A; Penot-Ragon C; Perrin G; Loundou A; Jaber S; Arnal JM; Perez D; Seghboyan JM; Constantin JM; Courant P; Lefrant JY; Guérin C; Prat G; Morange S; Roch A;
    N Engl J Med; 2010 Sep; 363(12):1107-16. PubMed ID: 20843245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with neuromuscular blocking agents and the risk of in-hospital mortality among mechanically ventilated patients with severe sepsis.
    Steingrub JS; Lagu T; Rothberg MB; Nathanson BH; Raghunathan K; Lindenauer PK
    Crit Care Med; 2014 Jan; 42(1):90-6. PubMed ID: 23982029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Comparison of Midazolam and Propofol for Deep Sedation in Patients with Acute Respiratory Distress Syndrome Requiring Neuromuscular Blocking Agents.
    Addison JD; Daley MJ; Curran M; Hodge EK
    J Pharm Pract; 2024 Apr; 37(2):271-278. PubMed ID: 36189765
    [No Abstract]   [Full Text] [Related]  

  • 9. Cisatracurium Continuous Infusion Versus No Neuromuscular Blockade for Acute Respiratory Distress Syndrome on Venovenous Extracorporeal Membrane Oxygenation.
    Kressin C; Thompson Bastin M; Ather A; Gopinath A; Srour H; Schadler A; Pandya K
    J Clin Pharmacol; 2021 Nov; 61(11):1415-1420. PubMed ID: 34180067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of early neuromuscular blockage in acute respiratory distress syndrome: A systematic review and meta-analyses of randomized clinical trials.
    Savoie-White FH; Tremblay L; Menier CA; Duval C; Bergeron F; Tadrous M; Tougas J; Guertin JR; Ugalde PA
    Heart Lung; 2023; 57():186-197. PubMed ID: 36242824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Implementation of Protocol-Based Utilization of Neuromuscular Blocking Agent Using Clinical Variables in Acute Respiratory Distress Syndrome Patients.
    Hadique S; Badami V; Forte M; Kovacic N; Umer A; Shigle A; Gardo J; Sangani R
    Crit Care Explor; 2021 Mar; 3(3):e0371. PubMed ID: 33786447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Observational Study of the Efficacy of Cisatracurium Compared with Vecuronium in Patients with or at Risk for Acute Respiratory Distress Syndrome.
    Sottile PD; Kiser TH; Burnham EL; Ho PM; Allen RR; Vandivier RW; Moss M;
    Am J Respir Crit Care Med; 2018 Apr; 197(7):897-904. PubMed ID: 29241014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
    Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Best evidence in critical care medicine: The role of neuromuscular blocking drugs in early severe acute respiratory distress syndrome.
    Needham CJ; Brindley PG
    Can J Anaesth; 2012 Jan; 59(1):105-8. PubMed ID: 22042702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
    Gates S; Perkins GD; Lamb SE; Kelly C; Thickett DR; Young JD; McAuley DF; Snaith C; McCabe C; Hulme CT; Gao Smith F
    Health Technol Assess; 2013 Sep; 17(38):v-vi, 1-87. PubMed ID: 24028755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early sedation and clinical outcomes of mechanically ventilated patients: a prospective multicenter cohort study.
    Tanaka LM; Azevedo LC; Park M; Schettino G; Nassar AP; Réa-Neto A; Tannous L; de Souza-Dantas VC; Torelly A; Lisboa T; Piras C; Carvalho FB; Maia Mde O; Giannini FP; Machado FR; Dal-Pizzol F; de Carvalho AG; dos Santos RB; Tierno PF; Soares M; Salluh JI;
    Crit Care; 2014 Jul; 18(4):R156. PubMed ID: 25047960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispectral Index for Titrating Sedation in ARDS Patients During Neuromuscular Blockade.
    Bass S; Vance ML; Reddy A; Bauer SR; Roach E; Torbic H; Welch S; Duggal A
    Am J Crit Care; 2019 Sep; 28(5):377-384. PubMed ID: 31474608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Effects of Gamma-Aminobutyric Acidergic Sedatives on Risk of Post-Extubation Delirium in the ICU: A Retrospective Cohort Study From a New England Health Care Network.
    Azimaraghi O; Wongtangman K; Wachtendorf LJ; Santer P; Rumyantsev S; Ahn C; Kiyatkin ME; Teja B; Sarge T; Subramaniam B; Eikermann M
    Crit Care Med; 2022 May; 50(5):e434-e444. PubMed ID: 34982739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries.
    Bellani G; Laffey JG; Pham T; Fan E; Brochard L; Esteban A; Gattinoni L; van Haren F; Larsson A; McAuley DF; Ranieri M; Rubenfeld G; Thompson BT; Wrigge H; Slutsky AS; Pesenti A; ;
    JAMA; 2016 Feb; 315(8):788-800. PubMed ID: 26903337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.